Centrum Medyczne Dietla 19 Sp. z o.o.

The medical center is at the forefront of ophthalmology research, focusing on innovative treatments for neovascular age-related macular degeneration (nAMD) and choroidal neovascularization secondary to pathologic myopia. The center's work in this field is pivotal in enhancing visual outcomes and quality of life for patients.

• Neovascular Age-Related Macular Degeneration (nAMD)
• Choroidal Neovascularization

Through comparative studies of novel therapies like RBS-001 and OPT-302, the center is advancing the understanding of treatment efficacy and safety, offering hope for improved management of these complex conditions.

Specializing in endocrinology, the medical center is dedicated to addressing thyroid eye disease, a challenging condition associated with thyroid dysfunction. The center's research is instrumental in developing targeted therapies that aim to reduce symptoms and improve patient outcomes.

• Thyroid Eye Disease

By evaluating the efficacy of treatments like satralizumab, the center is contributing to the development of more effective therapeutic strategies, enhancing the quality of life for individuals affected by this condition.